Ropivacaine (pf recalls

The FDA has published 2 recalls involving Ropivacaine (pf since 2017. The latest was reported on 13 Dec 2023. Most were for sterility. Staq Pharma has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.

Total recalls2since 2017

Last 12 months0reported

Class I00% of total

Ongoing0latest 13 Dec 2023

Recalls per month, last 24 months

click a bar for that month

0Oct '24 0 0 0Jan '25 0 0 0Apr 0 0 0Jul 0 0 0Oct 0 0 0Jan '26 0 0 0Apr 0 0 0Jul 0 0

Severity split

Class I 0 0%Class II 2 100%Class III 0 0%

Why ropivacaine (pf is recalled

Sterility150%
Packaging Defects150%

Companies

Staq Pharma150%
Banner Pharmacy Services150%

By year

2023150%
2017150%

All ropivacaine (pf recalls, newest first

2 total

Reported	Class	Recall	Company	Reason	Where
13 Dec 2023Drug	CLASS II	ROPivacaine HCl 0.2% PF in Sodium Chloride 1,000 mg recalled	Staq Pharma	Packaging Defects	Nationwide
1 Nov 2017Drug	CLASS II	Ropivacaine HCL (PF) 0.2% (2mg/mL) Cassette recalled	Banner Pharmacy Services	Sterility	Nationwide

Should you stop taking Ropivacaine (pf?

Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.